Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
27,615,000
-
Number of holders
-
8
-
Total 13F shares, excl. options
-
5,158,604
-
Shares change
-
+2,925,061
-
Total reported value, excl. options
-
$49,961,000
-
Value change
-
+$28,282,907
-
Number of buys
-
6
-
Number of sells
-
-1
-
Price
-
$9.68
Significant Holders of BiomX Inc. - Common stock, par value $0.0001 per share (PHGE) as of Q4 2019
9 filings reported holding PHGE - BiomX Inc. - Common stock, par value $0.0001 per share as of Q4 2019.
BiomX Inc. - Common stock, par value $0.0001 per share (PHGE) has 8 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5,158,604 shares
of 27,615,000 outstanding shares and own 18.7% of the company stock.
Largest 9 shareholders include ORBIMED ADVISORS LLC (2,313,489 shares), Johnson & Johnson Innovation - JJDC, Inc. (2,133,402 shares), RTW INVESTMENTS, LP (600,000 shares), Taylor Wealth Management Partners (50,518 shares), ExodusPoint Capital Management, LP (23,978 shares), Centiva Capital, LP (20,609 shares), K2 PRINCIPAL FUND, L.P. (16,608 shares), PANAGORA ASSET MANAGEMENT INC (0 shares), and J. Goldman & Co LP (150,000 shares).
This table shows the top 8 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.